Need a specific person's email?
Browse USC Roski Eye Institute's employee directory (about 69 employees) and reveal verified emails free.
USC Roski Eye Institute's most common email format is First.Last@med.usc.edu (ex. John.Doe@med.usc.edu), used for 54% of med.usc.edu addresses. USC Roski Eye Institute uses 8 email patterns across 2 domains: med.usc.edu and keckmedicine.org. Percentages are the share of addresses within each domain.
| Format | Example | Share of med.usc.edu |
|---|---|---|
| First.Last@med.usc.eduMost common | John.Doe@med.usc.edu | |
| FLast@med.usc.edu | JDoe@med.usc.edu | |
| Last_F@med.usc.edu | Doe_J@med.usc.edu | |
| Last@med.usc.edu | Doe@med.usc.edu |
| Format | Example | Share of keckmedicine.org |
|---|---|---|
| First@keckmedicine.orgMost common | John@keckmedicine.org | |
| First.Last@keckmedicine.org | John.Doe@keckmedicine.org | |
| FLast@keckmedicine.org | JDoe@keckmedicine.org | |
| Last@keckmedicine.org | Doe@keckmedicine.org |
Browse USC Roski Eye Institute's employee directory (about 69 employees) and reveal verified emails free.
Hospitals and Health CareCalifornia, United States51-200 Employees
The USC Roski Eye Institute operates within the Keck School of Medicine as a specialty ophthalmology center, staffed by full-time faculty physicians who cover all subspecialties. The institute evolved from the USC Department of Ophthalmology, founded in 1974, and has grown into a regional, national and global leader in eye care and research. Headquartered near downtown Los Angeles, it maintains clinics in Pasadena and Arcadia, serving the broader Southern California region. It is consistently ranked among the nation’s top ophthalmology programs, with top-10 recognition for more than two decades from U.S. News & World Report and Ophthalmology Times. Its mission centers on protecting, preserving and restoring sight through epidemiology research, advanced clinical care for complex eye conditions, and the adoption of emerging technologies to improve vision. Notable breakthroughs include the development of an FDA-approved retinal prosthesis, advances in stem cell therapy for age-related macular degeneration, and work identifying retinal cells implicated in a common childhood eye cancer.
Most common format
First.Last@med.usc.edu
Example: John.Doe@med.usc.edu
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.